Alterations in the functional capacity of albumin in patients with decompensated cirrhosis is associated with increased mortality†‡§

Abstract

The results of this study suggests marked dysfunction of albumin function in advanced cirrhosis and provide further evidence for damage to the circulating albumin, which is not reversed by MARS therapy. IMAR correlates with disease severity and may have prognostic use in acute-on-chronic liver failure.